Radionuclide Imaging in Patients with Ischemic Heart Failure(84 visite) Acampa W, Petretta M, Evangelista L, Petretta A, Cuocolo A
Current Medical Imaging Reviews (ISSN: 1573-4056), 2005 Jan; 1(1): N/D-N/D.
Tipo di articolo: Journal Article, Abstract, Conference,
Impact factor: 1.059, Impact factor a 5 anni: 0.855
Url: Non disponibile.
Parole chiave: Non disponibili.
Affiliazioni:
*** IBB - CNR ***
Riferimenti:
Non disponibile.
Nuclear imaging procedures are well-established diagnostic tools in clinical cardiology, providing noninvasive information about myocardial perfusion, cardiac function and metabolism. Scintigraphic parameters provide relevant information that aids in everyday clinical decision making for referring physicians. In patients with coronary artery disease, the presence of myocardial necrosis, postischemic stunning and hibernation can determine left ventricular dysfunction leading to ischemic heart failure. The prognosis of these patients is still poor and the long-term results of medical management remain discouraging. It is now well established that ventricular dysfunction is often a reversible process and ventricular function may improve following myocardial revascularization. Patients with extensive areas of hibernation treated medically have a worse prognosis as compared to those who undergo revascularization with a similar extent of viable myocardium. Therefore, an accurate non-invasive assessment of myocardial viability with the preoperative differentiation between hibernation and stunning and irreversibly necrotic tissue is important for clinical decision-making to select patients candidates for revascularization. Radionuclide imaging techniques evaluating myocardial perfusion, cell membrane integrity, ventricular function and cardiac metabolism have demonstrated clinical utility in the assessment of myocardial viability and in predicting improvement of ventricular function and prognosis after coronary revascularization.
Cusanno F, Cisbani E, Colilli S, Fratoni R, Garibaldi F, Giuliani F, Gricia M, Lucentini M, Magliozzi ML, Santarivenere F, Torrioli S, Cinti MN, Pani R, Pellegrini R, Simonetti G, Schillaci O, Del Vecchio S, Salvatore M, Majewski S, De Vincentis G, Scopinaro F * Results of clinical trials with SPEM(114 visite) Nucl Instrum Methods Phys Res Sect A, 2007 Feb 1; 497(1): 46-50. Impact Factor:3.221 DettagliEsporta in BibTeXEsporta in EndNote
Testino G, Leone S, Fagoonee S, Del Bas JM, Rodriguez B, Puiggros F, Marine S, Rodriguez MA, Morina D, Armengol L, Caimari A, Arola L, Cimini FA, Barchetta I, Carotti S, Bertoccini L, Baroni MG, Vespasiani-gentilucci U, Cavallo MG, Morini S, Nelson JE, Roth CL, Wilson LA, Yates KP, Aouizerat B, Morgan-stevenson V, Whalen E, Hoofnagle A, Mason M, Gersuk V, Yeh MM, Kowdley KV, Lee SM, Jun DW, Cho YK, Jang KS, Kucukazman M, Ata N, Dal K, Yeniova AO, Kefeli A, Basyigit S, Aktas B, Akin KO, Agladioglu K, Ure OS, Topal F, Nazligul Y, Beyan E, Ertugrul DT, Catena C, Cosma C, Camozzi V, Plebani M, Ermani M, Sechi LA, Fallo F, Goto Y, Ray MB, Mendenhall CL, French SW, Gartside PS Serum vitamin A deficiency and increased intrahepatic expression of cytokeratin antigen in alcoholic liver disease(9 visite) Hepatology (ISSN: 1827-1669electronic, 0026-4806linking), 1988 Sep; 83120693611123109(5): 1019-1026. Impact Factor:0.913 DettagliEsporta in BibTeXEsporta in EndNote
538 Records (382 escludendo Abstract e Conferenze). Impact factor totale: 1698.57 (1163.901 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 1863.691 (1257.026 escludendo Abstract e Conferenze).
ibb.cnr.it